These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28078638)

  • 41. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
    Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.
    Susheela SP; Revannasiddaiah S; Madhusudhan N; Bijjawara M
    J Cancer Res Ther; 2013; 9(4):715-7. PubMed ID: 24518724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
    Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice.
    Dandois V; Rommel D; Renard L; Jamart J; Cosnard G
    J Neuroradiol; 2010 May; 37(2):89-97. PubMed ID: 19570578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.
    Takano K; Kinoshita M; Arita H; Okita Y; Chiba Y; Kagawa N; Fujimoto Y; Kishima H; Kanemura Y; Nonaka M; Nakajima S; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):44-50. PubMed ID: 26381556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
    Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
    J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodal Imaging of Patients With Gliomas Confirms
    Laukamp KR; Lindemann F; Weckesser M; Hesselmann V; Ligges S; Wölfer J; Jeibmann A; Zinnhardt B; Viel T; Schäfers M; Paulus W; Stummer W; Schober O; Jacobs AH
    Mol Imaging; 2017 Jan; 16():1536012116687651. PubMed ID: 28654379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
    Munck Af Rosenschold P; Costa J; Engelholm SA; Lundemann MJ; Law I; Ohlhues L; Engelholm S
    Neuro Oncol; 2015 May; 17(5):757-63. PubMed ID: 25537018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging Spectrum and Pitfalls of (11)C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial Lesions.
    Ito K; Matsuda H; Kubota K
    Korean J Radiol; 2016; 17(3):424-34. PubMed ID: 27134530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
    Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
    Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of diffusion tensor imaging and
    Kinoshita M; Arita H; Okita Y; Kagawa N; Kishima H; Hashimoto N; Tanaka H; Watanabe Y; Shimosegawa E; Hatazawa J; Fujimoto Y; Yoshimine T
    J Neurosurg; 2016 Nov; 125(5):1136-1142. PubMed ID: 26918477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.